Wataru Ogawa

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 59

Top Topics

Insulin Resistance

Transcription Factor

Myasthenia Gravis

Top Venues

Journal of diabetes investigation

Endocrine journal

European journal of endocrinology

Diabetology international

This page only lists publications with an associated author ORCID identifier.

Publications

Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation 15 (9) (2024)
Wataru Ogawa, Palvi Gupta
The humanistic and societal impact of obesity in Japan: a targeted literature review. Endocrine journal 71 (3) (2024)
Wataru Ogawa, Palvi Gupta
The humanistic and societal impact of obesity in Japan: a targeted literature review. Endocrine journal 71 (3) (2024)
Wataru Ogawa, Palvi Gupta
The humanistic and societal impact of obesity in Japan: a targeted literature review. Endocrine journal (2024)
Tomoko Yamada, Hikaru Sugimoto, Ken-Ichi Hironaka, Yasuko Morita, Hiroshi Miura, Natsu Otowa-Suematsu, Yuko Okada, Yushi Hirota, Kazuhiko Sakaguchi, Shinya Kuroda, Wataru Ogawa
Mathematical Models of the Effect of Glucagon on Glycemia in Individuals With Type 2 Diabetes Treated With Dapagliflozin. Journal of the Endocrine Society 8 (6) (2024)
Maki Kanzawa, Hiroki Shichi, Keitaro Kanie, Masaaki Yamamoto, Naoki Yamamoto, Yasutaka Tsujimoto, Hironori Bando, Genzo Iguchi, Shigehisa Kitano, Naoko Inoshita, Shozo Yamada, Wataru Ogawa, Tomoo Itoh, Hidenori Fukuoka
Effects of the cortisol milieu on tumor-infiltrating immune cells (TIICs) in corticotroph tumors. Endocrinology (2024)
Shin Urai, Genzo Iguchi, Keitaro Kanie, Hironori Bando, Masaaki Yamamoto, Yuka Oi, Yuya Kashitani, Keiji Iida, Maki Kanzawa, Hidenori Fukuoka, Michiko Takahashi, Yasushi Shintani, Wataru Ogawa, Yutaka Takahashi
Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition. European journal of endocrinology 190 (1) (2024)
Tomoko Yamada, Hikaru Sugimoto, Ken-Ichi Hironaka, Yasuko Morita, Hiroshi Miura, Natsu Otowa-Suematsu, Yuko Okada, Yushi Hirota, Kazuhiko Sakaguchi, Shinya Kuroda, Wataru Ogawa
Mathematical Models of the Effect of Glucagon on Glycemia in Individuals With Type 2 Diabetes Treated With Dapagliflozin. Journal of the Endocrine Society 8 (6) (2024)
Masako Tomimoto, Kenji Tanimura, Naohisa Masuko, Akiko Uchida, Hitomi Imafuku, Masashi Deguchi, Akane Yamamoto, Yushi Hirota, Wataru Ogawa, Yoshito Terai
Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24-28 gestational weeks. Journal of diabetes investigation (2024)
Shin Urai, Seiji Tomofuji, Hironori Bando, Maki Kanzawa, Masaaki Yamamoto, Hidenori Fukuoka, Masahiro Tsuda, Genzo Iguchi, Wataru Ogawa
The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: A case with review of literature. Journal of neuroendocrinology 36 (6) (2024)
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation 15 (9) (2024)
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation 15 (9) (2024)
Wataru Ogawa, Palvi Gupta
The humanistic and societal impact of obesity in Japan: a targeted literature review. Endocrine journal 71 (3) (2024)
Shin Urai, Seiji Tomofuji, Hironori Bando, Maki Kanzawa, Masaaki Yamamoto, Hidenori Fukuoka, Masahiro Tsuda, Genzo Iguchi, Wataru Ogawa
The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: A case with review of literature. Journal of neuroendocrinology 36 (6) (2024)
Shin Urai, Genzo Iguchi, Keitaro Kanie, Hironori Bando, Masaaki Yamamoto, Yuka Oi, Yuya Kashitani, Keiji Iida, Maki Kanzawa, Hidenori Fukuoka, Michiko Takahashi, Yasushi Shintani, Wataru Ogawa, Yutaka Takahashi
Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition. European journal of endocrinology 190 (1) (2024)
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation (2024)
Shin Urai, Seiji Tomofuji, Hironori Bando, Maki Kanzawa, Masaaki Yamamoto, Hidenori Fukuoka, Masahiro Tsuda, Genzo Iguchi, Wataru Ogawa
The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: A case with review of literature. Journal of neuroendocrinology (2024)
Wataru Ogawa, Tatsuhiko Urakami, Takashi Kadowaki, Kalvin Kao, Laura Brandner, Kenichiro Shimizu, Timothy C Dunn
Glycemic metrics in Japanese isCGM users - Analysis by diabetes type and therapy. Journal of diabetes investigation (2024)
Kojiro Ishii, Wataru Ogawa, Yutaka Kimura, Toru Kusakabe, Ryo Miyazaki, Kiyoshi Sanada, Noriko Satoh-Asahara, Yuki Someya, Yoshifumi Tamura, Kohjiro Ueki, HIdetaka Wakabayashi, Yuya Watanabe, Minoru Yamada, Hidenori Arai
Diagnosis of sarcopenic obesity in Japan: Consensus statement of the Japanese Working Group on Sarcopenic Obesity. Geriatrics & gerontology international (2024)
Tomoko Yamada, Hikaru Sugimoto, Ken-Ichi Hironaka, Yasuko Morita, Hiroshi Miura, Natsu Otowa-Suematsu, Yuko Okada, Yushi Hirota, Kazuhiko Sakaguchi, Shinya Kuroda, Wataru Ogawa
Mathematical Models of the Effect of Glucagon on Glycemia in Individuals With Type 2 Diabetes Treated With Dapagliflozin. Journal of the Endocrine Society 8 (6) (2024)
Maki Kanzawa, Hiroki Shichi, Keitaro Kanie, Masaaki Yamamoto, Naoki Yamamoto, Yasutaka Tsujimoto, Hironori Bando, Genzo Iguchi, Shigehisa Kitano, Naoko Inoshita, Shozo Yamada, Wataru Ogawa, Tomoo Itoh, Hidenori Fukuoka
Effects of the Cortisol Milieu on Tumor-Infiltrating Immune Cells in Corticotroph Tumors. Endocrinology 165 (4) (2024)
Quan Yingyue, Kenji Sugawara, Harumi Takahashi, Norihide Yokoi, Kento Ohbayashi, Yusaku Iwasaki, Susumu Seino, Wataru Ogawa
Stimulatory effect of imeglimin on incretin secretion. Journal of diabetes investigation (2023)
Hitomi Imafuku, Kenji Tanimura, Naohisa Masuko, Masako Tomimoto, Yutoku Shi, Akiko Uchida, Masashi Deguchi, Kazumichi Fujioka, Akane Yamamoto, Kei Yoshino, Yushi Hirota, Wataru Ogawa, Yoshito Terai
Advantages of sensor-augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus. Journal of diabetes investigation (2023)
Wataru Ogawa, Yushi Hirota, Shigeru Miyazaki, Tadashi Nakamura, Yoshihiro Ogawa, Iichiro Shimomura, Toshimasa Yamauchi, Koutaro Yokote, null null
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocrine journal 71 (3) (2023)
Yusei Hosokawa, Tetsuya Hosooka, Makoto Imamori, Kanji Yamaguchi, Yoshito Itoh, Wataru Ogawa
Adipose tissue insulin resistance exacerbates liver inflammation and fibrosis in a diet-induced NASH model. Hepatology communications 7 (6) (2023)
Kyosuke Sato, Kenji Sugawara, Wataru Ogawa
A novel view of the insulin signaling pathway based on prediction of protein structure by the AI platform AlphaFold. Journal of diabetes investigation (2023)
Wataru Ogawa, Yushi Hirota, Shigeru Miyazaki, Tadashi Nakamura, Yoshihiro Ogawa, Iichiro Shimomura, Toshimasa Yamauchi, Koutaro Yokote, null null
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocrine journal (2023)
Wataru Ogawa, Yushi Hirota, Shigeru Miyazaki, Tadashi Nakamura, Yoshihiro Ogawa, Iichiro Shimomura, Toshimasa Yamauchi, Koutaro Yokote, null null
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocrine journal 71 (3) (2023)
Hikaru Sugimoto, Ken-Ichi Hironaka, Tomoko Yamada, Kazuhiko Sakaguchi, Wataru Ogawa, Shinya Kuroda
DI/cle, a Measure Consisting of Insulin Sensitivity, Secretion, and Clearance, Captures Diabetic States. The Journal of clinical endocrinology and metabolism (2023)
Shin Urai, Genzo Iguchi, Keitaro Kanie, Hironori Bando, Masaaki Yamamoto, Yuka Oi, Yuya Kashitani, Keiji Iida, Maki Kanzawa, Hidenori Fukuoka, Michiko Takahashi, Yasushi Shintani, Wataru Ogawa, Yutaka Takahashi
Clinical features of anti-PIT-1 hypophysitis: A new aspect of paraneoplastic autoimmune condition. European journal of endocrinology (2023)
Wataru Ogawa, Eiichi Araki, Yasushi Ishigaki, Yushi Hirota, Hiroshi Maegawa, Toshimasa Yamauchi, Tohru Yorifuji, Hideki Katagiri
New classification and diagnostic criteria for insulin resistance syndrome. Diabetology international 13 (2) (2022)
Masaki Suzuki, Shin Urai, Hidenori Fukuoka, Yushi Hirota, Masaaki Yamamoto, Yuko Okada, Naoki Yamamoto, Hiroki Shichi, Yasunori Fujita, Keitaro Kanie, Genzo Iguchi, Yutaka Takahashi, Wataru Ogawa
Relation between the insulin lowering rate and changes in bone mineral density: Analysis among subtypes of type 1 diabetes mellitus. Journal of diabetes investigation 13 (9) (2022)
Yushi Hirota, Yongjin Xu, Akane Yamamoto, Atsuko Matsuoka, Timothy C Dunn, Wataru Ogawa
Type 1 diabetes iron-deficiency anaemia case report and the clinical relevance of red blood cell lifespan-adjusted glycated haemoglobin. Diabetes, obesity & metabolism (2022)
Kenji Sugawara, Wataru Ogawa
New mechanism of metformin action mediated by lysosomal presenilin enhancer 2. Journal of diabetes investigation (2022)
Yuko Nabatame, Tetsuya Hosooka, Chikako Aoki, Yusei Hosokawa, Makoto Imamori, Yoshikazu Tamori, Yuko Okamatsu-Ogura, Takeshi Yoneshiro, Shingo Kajimura, Masayuki Saito, Wataru Ogawa
Kruppel-like factor 15 regulates fuel switching between glucose and fatty acids in brown adipocytes. Journal of diabetes investigation 12 (7) (2021)
Natsu Otowa-Suematsu, Kazuhiko Sakaguchi, Akihiro Kaneko, Jun Ito, Yasuko Morita, Hiroshi Miura, Tomoko Yamada, Anna So, Hisako Komada, Yuko Okada, Yushi Hirota, Yoshikazu Tamori, Wataru Ogawa
Relation of cardiac function to insulin resistance as evaluated by hyperinsulinemic-euglycemic clamp analysis in individuals with type 2 diabetes. Journal of diabetes investigation (2021)
Hiroshi Miura, Kazuhiko Sakaguchi, Wataru Ogawa, Yoshikazu Tamori
Clinical features of 65-year-old individuals in Japan diagnosed with possible sarcopenia based on the Asian Working Group for Sarcopenia 2019 criteria. Geriatrics & gerontology international 21 (8) (2021)
Mayuko Harada Yamada, Kazuya Fujihara, Satoru Kodama, Takaaki Sato, Taeko Osawa, Yuta Yaguchi, Masahiko Yamamoto, Masaru Kitazawa, Yasuhiro Matsubayashi, Takaho Yamada, Hiroyasu Seida, Wataru Ogawa, Hirohito Sone
Associations of Systolic Blood Pressure and Diastolic Blood Pressure With the Incidence of Coronary Artery Disease or Cerebrovascular Disease According to Glucose Status. Diabetes care 44 (9) (2021)
Kenji Sugawara, Wataru Ogawa
The gut microbial metabolite imidazole propionate inhibits metformin action. Journal of diabetes investigation 12 (8) (2021)
Hitomi Tsuchida, Yasuko Morita, Munenobu Nogami, Wataru Ogawa
Metformin action in the gut-insight provided by [ 18 F]FDG PET imaging. Diabetology international 13 (1) (2021)
Qiuhe Ji, Linong Ji, Yi-Ming Mu, Jiajun Zhao, Bernard Zinman, Christoph Wanner, Jyothis T George, Isabella Zwiener, Kohjiro Ueki, Koutaro Yokote, Wataru Ogawa, Odd Erik Johansen
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA-REG OUTCOME trial with a focus on Asia. Diabetes, obesity & metabolism 23 (8) (2021)
Jun Ito, Munenobu Nogami, Yasuko Morita, Kazuhiko Sakaguchi, Hisako Komada, Yushi Hirota, Kenji Sugawara, Yoshikazu Tamori, Feibi Zeng, Takamichi Murakami, Wataru Ogawa
Dose-dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by 18 F-labelled fluorodeoxyglucose positron emission tomography-MRI. Diabetes, obesity & metabolism 23 (3) (2020)
Yasuko Morita, Munenobu Nogami, Kazuhiko Sakaguchi, Yuko Okada, Yushi Hirota, Kenji Sugawara, Yoshikazu Tamori, Feibi Zeng, Takamichi Murakami, Wataru Ogawa
Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [18F]Fluorodeoxyglucose PET-MRI. Diabetes care 43 (8) (2020)
Hiroyuki Yamamoto, Toshiro Shinke, Hiromasa Otake, Hiroyuki Kawamori, Takayoshi Toba, Masaru Kuroda, Yushi Hirota, Kazuhiko Sakaguchi, Wataru Ogawa, Ken-Ichi Hirata
Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy. Journal of diabetes investigation 12 (6) (2020)
Wataru Ogawa, Yushi Hirota, Takeshi Osonoi, Takahiro Tosaki, Yoshiro Kato, Kazunori Utsunomiya, Rimei Nishimura, Jiro Nakamura
Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan. Journal of diabetes investigation 12 (1) (2020)
Kenji Sugawara, Yuko Okada, Yushi Hirota, Kazuhiko Sakaguchi, Wataru Ogawa
Relationship between metformin use and vitamin B12 status in patients with type 2 diabetes in Japan. Journal of diabetes investigation 11 (4) (2020)
Yusei Hosokawa, Wataru Ogawa
SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use. Journal of diabetes investigation 11 (6) (2020)
Ryo Kushi, Yushi Hirota, Wataru Ogawa
Insulin resistance and exaggerated insulin sensitivity triggered by single-gene mutations in the insulin signaling pathway. Diabetology international 12 (1) (2020)
Naofumi Yoshida, Seiichi Kitahama, Tomoya Yamashita, Yasuko Hirono, Tokiko Tabata, Yoshihiro Saito, Ryohei Shinohara, Hitomi Nakashima, Takuo Emoto, Yushi Hirota, Tetsuya Takahashi, Wataru Ogawa, Ken-Ichi Hirata
Metabolic alterations in plasma after laparoscopic sleeve gastrectomy. Journal of diabetes investigation 12 (1) (2020)
Atsuko Matsuoka, Yushi Hirota, Akihiko Takeda, Minoru Kishi, Naoko Hashimoto, Takeshi Ohara, Satomi Higo, Hiroyuki Yamada, Tomoaki Nakamura, Tetsushi Hamaguchi, Takehito Takeuchi, Yasushi Nakagawa, Yuko Okada, Kazuhiko Sakaguchi, Wataru Ogawa
Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: A multicenter cross-sectional study. Journal of diabetes investigation 11 (2) (2019)
Hiroshi Miura, Kazuhiko Sakaguchi, Yuko Okada, Tomoko Yamada, Natsu Otowa-Suematsu, Anna So, Hisako Komada, Yushi Hirota, Takeshi Ohara, Yasuo Kuroki, Kenta Hara, Tomokazu Matsuda, Minoru Kishi, Akihiko Takeda, Kazuki Yokota, Yoshikazu Tamori, Wataru Ogawa
Effects of ipragliflozin on glycemic control, appetite and its related hormones: A prospective, multicenter, open-label study (SOAR-KOBE Study). Journal of diabetes investigation 10 (5) (2019)
Yasuko Ohara, Yuko Okada, Tomoko Yamada, Kenji Sugawara, Masayuki Kanatani, Hidenori Fukuoka, Yushi Hirota, Takaki Maeda, Naoya Morisada, Kazumoto Iijima, Wataru Ogawa
Phenotypic differences and similarities of monozygotic twins with maturity-onset diabetes of the young type 5. Journal of diabetes investigation 10 (4) (2019)
Wataru Ogawa, Yushi Hirota
Sodium-glucose cotransporter 2 inhibitor-associated diabetic ketoacidosis in patients with type 1 diabetes: Metabolic imbalance as an underlying mechanism. Journal of diabetes investigation 10 (4) (2019)
Shinsuke Nakajima, Yuki Nishimoto, Sanshiro Tateya, Yasuyuki Iwahashi, Yuko Okamatsu-Ogura, Masayuki Saito, Wataru Ogawa, Yoshikazu Tamori
Fat-specific protein 27α inhibits autophagy-dependent lipid droplet breakdown in white adipocytes. Journal of diabetes investigation 10 (6) (2019)
Hisako Komada, Yushi Hirota, Wataru Ogawa
Glucagon secretions are impaired in patients with fulminant type 1 diabetes. Journal of diabetes investigation 10 (3) (2019)
Takehito Takeuchi, Yasushi Ishigaki, Yushi Hirota, Yutaka Hasegawa, Tohru Yorifuji, Hiroko Kadowaki, Takashi Akamizu, Wataru Ogawa, Hideki Katagiri
Clinical characteristics of insulin resistance syndromes: A nationwide survey in Japan. Journal of diabetes investigation 11 (3) (2019)
Ayumi Kanno, Shun-Ichiro Asahara, Mao Kawamura, Ayuko Furubayashi, Shoko Tsuchiya, Emi Suzuki, Tomoko Takai, Maki Koyanagi-Kimura, Tomokazu Matsuda, Yuko Okada, Wataru Ogawa, Yoshiaki Kido
Early administration of dapagliflozin preserves pancreatic β-cell mass through a legacy effect in a mouse model of type 2 diabetes. Journal of diabetes investigation 10 (3) (2018)
Takahiro Minamii, Munenobu Nogami, Wataru Ogawa
Mechanisms of metformin action: In and out of the gut. Journal of diabetes investigation 9 (4) (2018)
Kenji Sugawara, Kazuhiro Nomura, Yuko Okada, Aki Sugano, Masaaki Matsumoto, Toru Takarada, Atsuko Takeuchi, Hiroyuki Awano, Yushi Hirota, Hisahide Nishio, Yutaka Takaoka, Wataru Ogawa
In silico and in vitro analyses of the pathological relevance of the R258H mutation of hepatocyte nuclear factor 4α identified in maturity-onset diabetes of the young type 1. Journal of diabetes investigation 10 (3) (2018)